P02649 (APOE_HUMAN) Homo sapiens (Human)
Apolipoprotein E UniProtKBInterProSTRINGInteractive Modelling
317 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: A0A0S2Z3D5
Available Structures
29 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of a computationally designed protein (LD3) in complex with BCL-2 |
Heteromer P10415; | 91.55 | 2×SO4; | |||
| APOE4 receptor in complex with APOE4 NTD |
Heteromer Q6PI73; | 99.28 | ||||
| Crystal structure of a proteolytically cleaved, amino terminal domain of apolipoprotein E3 | homo-2-mer | 100 | 1×PO4; | |||
| NMR Structure of full length apoE3 | monomer | 98.33 | ||||
| NMR solution structure of complete receptor binding domain of human apolipoprotein E | monomer | 100 | ||||
| Apolipoprotein E4, 22k domain | monomer | 99.31 | ||||
| APOLIPOPROTEIN E3 (APO-E3), TRUNCATION MUTANT 165 | monomer | 100 | ||||
| Rationally Designed ED1 Epitope-Scaffold Immunogen for SARS-CoV-2 | monomer | 96.53 | 1×GOL; 1×PEG; 1×ACT; | |||
| THREE-DIMENSIONAL STRUCTURE OF THE LDL RECEPTOR-BINDING DOMAIN OF HUMAN APOLIPOPROTEIN E | monomer | 100 | ||||
| STRUCTURAL BASIS FOR ALTERED FUNCTION IN THE COMMON MUTANTS OF HUMAN APOLIPOPROTEIN-E | monomer | 99.31 | ||||
| Human Apolipoprotein E4 (ApoE4) N-terminal domain (space group P212121) | monomer | 99.3 | ||||
| APOLIPOPROTEIN E3 (APOE3), TRIGONAL TRUNCATION MUTANT 165 | monomer | 100.0 | ||||
| N-terminal domain of human apolipoprotein E | monomer | 99.3 | 1×GOL; | |||
| N-terminal domain of human apolipoprotein E | monomer | 99.3 | ||||
| APOLIPOPROTEIN E3 (APOE3) | monomer | 100.0 | ||||
| Crystal structure of the N-terminal domain of mutants of Human Apolipoprotein-E (ApoE) | monomer | 99.27 | 2×NA; | |||
| Crystal structure of the N-terminal domain of mutants of Human Apolipoprotein-E (ApoE) | monomer | 99.26 | 3×NA; | |||
| APOLIPOPROTEIN E2 (APOE2, D154A MUTATION) | monomer | 98.47 | ||||
| APOLIPOPROTEIN E3 (APOE3) TRUNCATION MUTANT 165 | monomer | 100.0 | ||||
| Human Apolipoprotein E4 (ApoE4) N-terminal domain (space group P3121) | monomer | 99.26 | ||||
| Apolipoprotein E3 22kD fragment LYS146GLN mutant | monomer | 99.29 | ||||
| Apolipoprotein E3 22kD fragment LYS146GLU mutant | monomer | 99.29 | ||||
| APOLIPOPROTEIN E4 (APOE4), 22K FRAGMENT | monomer | 99.28 | ||||
| Fragment-based Discovery of an apoE4 Stabilizer | monomer | 99.28 | 1×KQP; | |||
| Fragment-based Discovery of an apoE4 Stabilizer | monomer | 99.28 | 1×KJM; | |||
| STRUCTURAL BASIS FOR ALTERED FUNCTION IN THE COMMON MUTANTS OF HUMAN APOLIPOPROTEIN-E | monomer | 99.28 | ||||
| PEPTIDE OF HUMAN APOE RESIDUES 263-286, NMR, 5 STRUCTURES AT PH 4.8, 37 DEGREES CELSIUS AND PEPTIDE… | monomer | 100 | ||||
| PEPTIDE OF HUMAN APOE RESIDUES 267-289, NMR, 5 STRUCTURES AT PH 6.0, 37 DEGREES CELSIUS AND PEPTIDE… | monomer | 100 | ||||
| Fusion construct of CR17 from LRP-1 and ApoE residues 130-149 | monomer | 100 | 1×CA; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1ya9.1.A | monomer | 0.71 | 80.45 | |||
| 2l7b.1.A | monomer | 0.66 | 98.33 | |||